Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Head and Neck Cancer

Free Subscription Articles published in Cancer Retrieve available abstracts of 90 articles: HTML format Text format

Single Articles

February 2012
1. GOURZONES C , Jimenez AS, Busson P
   Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
   Cancer. 2012 Feb 1. doi: 10.1002/cncr.26514.
   PubMed     Text format     Related articles   
   
   
   
   
2. WONG AM , Tsang JW, Guan XY
   Reply to profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
   Cancer. 2012 Feb 1. doi: 10.1002/cncr.26513.
   PubMed     Text format     Related articles   
   
   
   
   January 2012
3. HIURA Y , Takiguchi S, Yamamoto K, Takahashi T, et al
   Effects of ghrelin administration during chemotherapy with advanced esophageal cancer patients: A prospective, randomized, placebo-controlled phase 2 study.
   Cancer. 2012 Jan 26. doi: 10.1002/cncr.27430.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
4. LANGER CJ
   Exploring biomarkers in head and neck cancer.
   Cancer. 2012 Jan 26. doi: 10.1002/cncr.26718.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
5. DANSKY ULLMANN C , Harlan LC, Shavers VL, Stevens JL, et al
   A population-based study of therapy and survival for patients with head and neck cancer treated in the community.
   Cancer. 2012 Jan 17. doi: 10.1002/cncr.27419.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   December 2011
6. CHEN MF , Lu MS, Lin PY, Chen PT, et al
   The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma.
   Cancer. 2011 Dec 27. doi: 10.1002/cncr.26736.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
7. PAN JY , Ajani JA, Gu J, Gong Y, et al
   Association of Aurora-A (STK15) kinase polymorphisms with clinical outcome of esophageal cancer treated with preoperative chemoradiation.
   Cancer. 2011 Dec 27. doi: 10.1002/cncr.26581.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
8. CHAN YW , Chow VL, Wei WI
   Quality of life of patients after salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma.
   Cancer. 2011 Dec 16. doi: 10.1002/cncr.26719.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
9. MENG Z , Garcia MK, Hu C, Chiang J, et al
   Randomized controlled trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma.
   Cancer. 2011 Nov 9. doi: 10.1002/cncr.26550.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. SUZUKI A , Xiao L, Hayashi Y, Macapinlac HA, et al
    Prognostic significance of baseline positron emission tomography and importance of clinical complete response in patients with esophageal or gastroesophageal junction cancer treated with definitive chemoradiotherapy.
    Cancer. 2011;117:4823-33.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    October 2011
11. USUI A , Hoshino I, Akutsu Y, Sakata H, et al
    The molecular role of Fra-1 and its prognostic significance in human esophageal squamous cell carcinoma.
    Cancer. 2011 Oct 25. doi: 10.1002/cncr.26652.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. MERKOW RP , Bilimoria KY, McCarter MD, Chow WB, et al
    Effect of histologic subtype on treatment and outcomes for esophageal cancer in the United States.
    Cancer. 2011 Oct 17. doi: 10.1002/cncr.26608.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. ILSON DH , Minsky BD, Ku GY, Rusch V, et al
    Phase 2 trial of induction and concurrent chemoradiotherapy with weekly irinotecan and cisplatin followed by surgery for esophageal cancer.
    Cancer. 2011 Oct 11. doi: 10.1002/cncr.26591.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
14. CAO W , Feng Z, Cui Z, Zhang C, et al
    Up-regulation of enhancer of zeste homolog 2 is associated positively with cyclin D1 overexpression and poor clinical outcome in head and neck squamous cell carcinoma.
    Cancer. 2011 Oct 11. doi: 10.1002/cncr.26575.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. CAUDELL JJ , Carroll WR, Spencer SA, Bonner JA, et al
    Examination of laryngoesophageal dysfunction-free survival as an endpoint in nonsurgical treatment of squamous cell carcinomas of the larynx and hypopharynx.
    Cancer. 2011;117:4447-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. EBRAHIMI A , Murali R, Gao K, Elliott MS, et al
    The prognostic and staging implications of bone invasion in oral squamous cell carcinoma.
    Cancer. 2011;117:4460-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2011
17. CASANOVA M , Bisogno G, Gandola L, Cecchetto G, et al
    A prospective protocol for nasopharyngeal carcinoma in children and adolescents: The Italian Rare Tumors in Pediatric Age (TREP) project.
    Cancer. 2011 Sep 14. doi: 10.1002/cncr.26528.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2011
18. LAHMANN PH , Pandeya N, Webb PM, Green AC, et al
    Body mass index, long-term weight change, and esophageal squamous cell carcinoma: Is the inverse association modified by smoking status?
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26455.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
19. AZAD AK , Bairati I, Samson E, Cheng D, et al
    Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancers.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26446.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. WOUTERS MW , Gooiker GA, van Sandick JW, Tollenaar RA, et al
    The volume-outcome relation in the surgical treatment of esophageal cancer: A systematic review and meta-analysis.
    Cancer. 2011 Aug 25. doi: 10.1002/cncr.26383.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
21. MENDELSON J , Song S, Li Y, Maru DM, et al
    Dysfunctional transforming growth factor-beta signaling with constitutively active Notch signaling in Barrett's esophageal adenocarcinoma.
    Cancer. 2011;117:3691-702.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
22. MUSCAT JE , Ahn K, Richie JP Jr, Stellman SD, et al
    Nicotine dependence phenotype, time to first cigarette, and risk of head and neck cancer.
    Cancer. 2011 Aug 8. doi: 10.1002/cncr.26235.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
23. ARGIRIS A , Ghebremichael M, Burtness B, Axelrod RS, et al
    A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303).
    Cancer. 2011;117:3374-82.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2011
24. XU L , Li G, Wei Q, El-Naggar AK, et al
    Family history of cancer and risk of sporadic differentiated thyroid carcinoma.
    Cancer. 2011 Jul 28. doi: 10.1002/cncr.26398.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. ZHANG H , Travis LB, Chen R, Hyrien O, et al
    Impact of radiotherapy on laryngeal cancer survival: A Population-Based Study of 13,808 US Patients.
    Cancer. 2011 Jul 19. doi: 10.1002/cncr.26357.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
26. GILBERT J , Murphy B, Dietrich MS, Henry E, et al
    Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancer.
    Cancer. 2011 Jul 15. doi: 10.1002/cncr.26364.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. VLATKOVIC N , El-Fert A, Devling T, Ray-Sinha A, et al
    Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Cancer. 2011;117:2939-50.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. COOLEY ME , Emmons KM, Haddad R, Wang Q, et al
    Patient-reported receipt of and interest in smoking-cessation interventions after a diagnosis of cancer.
    Cancer. 2011;117:2961-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. SANDULACHE VC , Ow TJ, Pickering CR, Frederick MJ, et al
    Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
    Cancer. 2011;117:2926-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. BELL A , Bell D, Weber RS, El-Naggar AK, et al
    CpG island methylation profiling in human salivary gland adenoid cystic carcinoma.
    Cancer. 2011;117:2898-909.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
31. EBRAHIMI A , Zhang WJ, Gao K, Clark JR, et al
    Nodal yield and survival in oral squamous cancer: Defining the standard of care.
    Cancer. 2011;117:2917-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    June 2011
32. SANDULACHE VC , Skinner HD, Ow TJ, Zhang A, et al
    Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
    Cancer. 2011 Jun 30. doi: 10.1002/cncr.26321.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. WONG AM , Kong KL, Tsang JW, Kwong DL, et al
    Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs.
    Cancer. 2011 Jun 30. doi: 10.1002/cncr.26309.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. ZHANG Y , Sturgis EM, Huang Z, Zafereo ME, et al
    Genetic variants of the p53 and p73 genes jointly increase risk of second primary malignancies in patients after index squamous cell carcinoma of the head and neck.
    Cancer. 2011 Jun 29. doi: 10.1002/cncr.26222.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
35. VAN TUBERGEN E , Vander Broek R, Lee J, Wolf G, et al
    Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Cancer. 2011;117:2677-89.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. CHOE KS , Haraf DJ, Solanki A, Cohen EE, et al
    Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
    Cancer. 2011 Jun 13. doi: 10.1002/cncr.26084.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
37. BROOKS HD , Glisson BS, Bekele BN, Ginsberg LE, et al
    Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
    Cancer. 2011;117:2112-9.
    PubMed     Text format     Related articles   
    
    
    
    
38. BRUYERE C , Lonez C, Duray A, Cludts S, et al
    Considering temozolomide as a novel potential treatment for esophageal cancer.
    Cancer. 2011;117:2004-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
39. CHU KP , Shema S, Wu S, Gomez SL, et al
    Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific Islanders.
    Cancer. 2011;117:1935-45.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
40. XIAO WW , Huang SM, Han F, Wu SX, et al
    Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: Long-term results of a phase 2 study.
    Cancer. 2011;117:1874-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
41. PARK HR , Kim SH, Lee SY, Sung JM, et al
    Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Cancer. 2011;117:1864-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    April 2011
42. CHEN SA , Muller S, Chen AY, Hudgins PA, et al
    Patterns of extralaryngeal spread of laryngeal cancer: Thyroid Cartilage Penetration Occurs in a Minority of Patients with Extralaryngeal Spread of Laryngeal Squamous Cell Cancers.
    Cancer. 2011 Apr 26. doi: 10.1002/cncr.26130.
    PubMed     Text format     Related articles   
    
    
    
    
43. LI YX , Liu QF, Wang WH, Jin J, et al
    Failure patterns and clinical implications in early stage nasal natural killer/T-cell lymphoma treated with primary radiotherapy.
    Cancer. 2011 Apr 26. doi: 10.1002/cncr.26167.
    PubMed     Text format     Related articles   
    
    
    
    
44. WONG SJ , Harari PM, Garden AS, Schwartz M, et al
    Longitudinal oncology registry of head and neck carcinoma (LORHAN): Analysis of chemoradiation treatment approaches in the United States.
    Cancer. 2011;117:1679-86.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
45. ALHAZZAZI TY , Kamarajan P, Joo N, Huang JY, et al
    Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.
    Cancer. 2011;117:1670-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
46. LANGEVIN SM , Stone RA, Bunker CH, Lyons-Weiler MA, et al
    MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2011;117:1454-62.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
47. ILSON DH , Kelsen D, Shah M, Schwartz G, et al
    A phase 2 trial of erlotinib in patients with previously treated squamous cell and adenocarcinoma of the esophagus.
    Cancer. 2011;117:1409-14.
    PubMed     Text format     Related articles   
    
    
    
    March 2011
48. WANG WY , Twu CW, Lin WY, Jiang RS, et al
    Plasma epstein-barr virus DNA screening followed by (18) F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma.
    Cancer. 2011 Mar 22. doi: 10.1002/cncr.26069.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
49. IYER NG , Morris LG, Tuttle RM, Shaha AR, et al
    Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Cancer. 2011 Mar 22. doi: 10.1002/cncr.26070.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
50. ZHANG Y , Sturgis EM, Zafereo ME, Wei Q, et al
    p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Cancer. 2011;117:1227-35.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
51. MATHUR A , Moses W, Rahbari R, Khanafshar E, et al
    Higher rate of BRAF mutation in papillary thyroid cancer over time: A single-institution study.
    Cancer. 2011 Mar 15. doi: 10.1002/cncr.26072.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    February 2011
52. FURY MG , Haque S, Stambuk H, Shen R, et al
    A phase 2 study of pemetrexed plus gemcitabine every 2 weeks for patients with recurrent or metastatic head and neck squamous cell cancer.
    Cancer. 2011;117:795-801.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
53. YU P , Clayman GL, Walsh GL
    Long-term outcomes of microsurgical reconstruction for large tracheal defects.
    Cancer. 2011;117:802-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
54. AN X , Wang FH, Ding PR, Deng L, et al
    Plasma Epstein-Barr virus DNA level strongly predicts survival in metastatic/recurrent nasopharyngeal carcinoma treated with palliative chemotherapy.
    Cancer. 2011 Feb 11. doi: 10.1002/cncr.25932.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
55. PRINTZ C
    Robotic surgery helps preserve speech after head and neck cancer surgery.
    Cancer. 2011;117:439.
    PubMed     Text format     Related articles   
    
    
    
    
56. PALERI V , Thomas L, Basavaiah N, Drinnan M, et al
    Oncologic outcomes of open conservation laryngectomy for radiorecurrent laryngeal carcinoma: A systematic review and meta-analysis of english-language literature.
    Cancer. 2011 Feb 1. doi: 10.1002/cncr.25831.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
57. CHEN YY , Zhao C, Wang J, Ma HL, et al
    Intensity-modulated radiation therapy reduces radiation-induced trismus in patients with nasopharyngeal carcinoma: A prospective study with >5 years of follow-up.
    Cancer. 2011 Jan 24. doi: 10.1002/cncr.25773.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
58. KAO J , Genden EM, Chen CT, Rivera M, et al
    Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer.
    Cancer. 2011 Jan 18. doi: 10.1002/cncr.25786.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
59. VLATKOVIC N , El-Fert A, Devling T, Ray-Sinha A, et al
    Loss of MTBP expression is associated with reduced survival in a biomarker-defined subset of patients with squamous cell carcinoma of the head and neck.
    Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
60. VAN TUBERGEN E , Vander Broek R, Lee J, Wolf G, et al
    Tristetraprolin regulates interleukin-6, which is correlated with tumor progression in patients with head and neck squamous cell carcinoma.
    Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
61. SANDULACHE VC , Ow TJ, Pickering CR, Frederick MJ, et al
    Glucose, not glutamine, is the dominant energy source required for proliferation and survival of head and neck squamous carcinoma cells.
    Cancer. 2011.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    December 2010
62. HAYASHI Y , Correa AM, Hofstetter WL, Vaporciyan AA, et al
    The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy.
    Cancer. 2010;116:5619-27.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
63. BELL D , Roberts D, Kies M, Rao P, et al
    Cell type-dependent biomarker expression in adenoid cystic carcinoma: biologic and therapeutic implications.
    Cancer. 2010;116:5749-56.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
64. WANG XS , Zhang YJ, Liu XL, Zhou ZR, et al
    The role of technetium-99m methoxyisobutyl isonitrile scintigraphy in predicting the therapeutic effect of chemotherapy against nasopharyngeal carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
65. ALHAZZAZI TY , Kamarajan P, Joo N, Huang JY, et al
    Sirtuin-3 (SIRT3), a novel potential therapeutic target for oral cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
66. BROOKS HD , Glisson BS, Bekele BN, Ginsberg LE, et al
    Phase 2 study of dasatinib in the treatment of head and neck squamous cell carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
67. PARK HR , Kim SH, Lee SY, Sung JM, et al
    Nuclear localization of Nm23-H1 in head and neck squamous cell carcinoma is associated with radiation resistance.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
68. XIAO WW , Huang SM, Han F, Wu SX, et al
    Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
69. CHU KP , Shema S, Wu S, Gomez SL, et al
    Head and neck cancer-specific survival based on socioeconomic status in Asians and Pacific islanders.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
70. HAYASHI Y , Correa AM, Hofstetter WL, Vaporciyan AA, et al
    The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
71. WONG SJ , Harari PM, Garden AS, Schwartz M, et al
    Longitudinal oncology registry of head and neck carcinoma (LORHAN): analysis of chemoradiation treatment approaches in the United States.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
72. ZHANG Y , Sturgis EM, Zafereo ME, Wei Q, et al
    p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
73. LANGEVIN SM , Stone RA, Bunker CH, Lyons-Weiler MA, et al
    MicroRNA-137 promoter methylation is associated with poorer overall survival in patients with squamous cell carcinoma of the head and neck.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
74. BRUYERE C , Lonez C, Duray A, Cludts S, et al
    Considering temozolomide as a novel potential treatment for esophageal cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
75. PRINTZ C
    Digital camera detects oral cancer cells.
    Cancer. 2010;116:4895.
    PubMed     Text format     Related articles   
    
    
    
    October 2010
76. KOUNTOURAKIS P , Correa AM, Hofstetter WL, Lee JH, et al
    Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
77. RASCH CR , Hauptmann M, Balm AJ
    Intra-arterial chemotherapy for head and neck cancer: is there a verdict?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
78. ROBBINS KT , Howell SB
    Reply to Intra-arterial chemotherapy for head and neck cancer: is there a verdict?
    Cancer. 2010.
    PubMed     Text format     Related articles   
    
    
    
    
79. PATNANA SV , Murthy SB, Xiao L, Rohren E, et al
    Critical role of surgery in patients with gastroesophageal carcinoma with a poor prognosis after chemoradiation as defined by positron emission tomography.
    Cancer. 2010;116:4487-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
80. KAO J , Genden EM, Gupta V, Policarpio EL, et al
    Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
81. MATTOX A , Hughes B, Oleson J, Reardon D, et al
    Treatment recommendations for primary extradural meningiomas.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
82. VRIENS MR , Moses W, Weng J, Peng M, et al
    Clinical and molecular features of papillary thyroid cancer in adolescents and young adults.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
83. SOUTTO M , Peng D, Razvi M, Ruemmele P, et al
    Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas.
    Cancer. 2010;116:4033-42.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    August 2010
84. GAUR P , Sepesi B, Hofstetter WL, Correa AM, et al
    Endoscopic esophageal tumor length: a prognostic factor for patients with esophageal cancer.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
85. CHEUK DK , Billups CA, Martin MG, Roland CR, et al
    Prognostic factors and long-term outcomes of childhood nasopharyngeal carcinoma.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
86. XI M , Liu MZ, Wang HX, Cai L, et al
    Radiation-induced sarcoma in patients with nasopharyngeal carcinoma: a single-institution study.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
87. RICE TW , Rusch VW, Ishwaran H, Blackstone EH, et al
    Cancer of the esophagus and esophagogastric junction: data-driven staging for the seventh edition of the American Joint Committee on Cancer/International Union Against Cancer Cancer Staging Manuals.
    Cancer. 2010;116:3763-73.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
88. REZENDE TM , Freire MD, Franco OL
    Head and neck cancer: proteomic advances and biomarker achievements.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
89. HESSEL AC , Moreno MA, Hanna EY, Roberts DB, et al
    Compliance with quality assurance measures in patients treated for early oral tongue cancer.
    Cancer. 2010;116:3408-16.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
90. IYENGAR P , Mazloom A, Shihadeh F, Berjawi G, et al
    Hodgkin lymphoma involving extranodal and nodal head and neck sites: characteristics and outcomes.
    Cancer. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: